Charles Schwab Investment Management Inc Assembly Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.35 - $2.29 $25,536 - $43,317	-18,916 Reduced 36.82%	32,452 $69,000
Q1 2022 May 13, 2022	BUY	$1.46 - $2.45 $74,997 - $125,851	51,368 New	51,368 $106,000
Q3 2021 Nov 16, 2021	SELL	$3.14 - $3.9 $609,304 - $756,779	-194,046 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $108,965 - $130,757	-28,675 Reduced 12.87%	194,046 $753,000
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $35,073 - $53,703	8,100 Added 3.77%	222,721 $1.03 Million
Q4 2020 Feb 16, 2021	SELL	$4.87 - $17.29 $95,700 - $339,765	-19,651 Reduced 8.39%	214,621 $1.3 Million
Q3 2020 Nov 13, 2020	BUY	$15.08 - $27.04 $349,795 - $627,219	23,196 Added 10.99%	234,272 $3.85 Million
Q2 2020 Aug 14, 2020	BUY	$14.57 - $23.96 $402,204 - $661,415	27,605 Added 15.05%	211,076 $4.92 Million
Q1 2020 May 15, 2020	BUY	$10.27 - $21.23 $300,767 - $621,741	29,286 Added 18.99%	183,471 $2.72 Million
Q4 2019 Feb 07, 2020	BUY	$8.36 - $23.81 $244,137 - $695,323	29,203 Added 23.37%	154,185 $3.16 Million
Q3 2019 Nov 08, 2019	BUY	$9.83 - $14.82 $786 - $1,185	80 Added 0.06%	124,982 $1.23 Million
Q2 2019 Aug 09, 2019	BUY	$12.9 - $20.8 $81,798 - $131,892	6,341 Added 5.35%	124,902 $1.69 Million
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $41,400 - $58,311	2,339 Added 2.01%	118,561 $2.34 Million
Q4 2018 Feb 14, 2019	BUY	$19.05 - $36.45 $28,441 - $54,419	1,493 Added 1.3%	116,222 $2.63 Million
Q3 2018 Nov 13, 2018	BUY	$34.41 - $44.23 $2.7 Million - $3.47 Million	78,363 Added 215.48%	114,729 $4.26 Million
Q2 2018 Aug 08, 2018	BUY	$39.21 - $50.29 $45,718 - $58,638	1,166 Added 3.31%	36,366 $1.43 Million
Q1 2018 May 07, 2018	BUY	$41.7 - $64.16 $158,460 - $243,808	3,800 Added 12.1%	35,200 $1.73 Million
Q4 2017 Jan 17, 2018	BUY	$28.58 - $49.91 $228,640 - $399,280	8,000 Added 34.19%	31,400 $1.42 Million
Q3 2017 Nov 13, 2017	BUY	$23.08 - $34.92 $540,072 - $817,128	23,400	23,400 $818,000

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$277,028
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account